Palantir Rebuts Maven Shutdown Fears as Wall Street Splits on What's Already Priced In

Palantir moved to calm European nerves over the future of a key NATO deployment on Wednesday, with Louis Mosley, the company's head for the UK and Europe, telling Reuters that neither Palantir nor the US government has the ability to switch off the Maven Smart System. His remarks, reported by Reuters, were aimed at fears that surfaced after disruptions to Starlink service in Ukraine.

The assurance carries weight for investors because it touches on something broader than one contract: whether governments feel safe building Palantir software into their defence architecture. Still, it is a narrow commitment. Mosley spoke specifically about Maven Smart System, not about every product Palantir sells or every government use case. The distinction matters — the technical question of a kill switch is not the same as the wider worry about dependence on American technology, and data-sovereignty concerns do not evaporate on the back of one statement.

Switzerland as a Case Study in Resistance

How real those reservations can be was laid out in a report published on 15 October by Republik and WAV. According to that account, the Swiss army and procurement agency Armasuisse evaluated Palantir products five separate times and turned them down on each occasion, with data-sovereignty concerns among the reasons. Those decisions arose in a different procurement setting from the NATO system and cannot be read as a verdict on Maven. What they do show is that interest in a product does not translate automatically into a purchase order — a gap investors would do well to keep in mind.

Two Banks, Two Very Different Messages

Against that political backdrop, the analyst community is sending mixed signals ahead of the company's next set of numbers. Citi lifted its price target to $250 from $245 on Wednesday and stuck with its Buy rating, citing encouraging feedback from partner conversations and positive intra-year checks in the US commercial and federal businesses. The bank expects US commercial revenue growth above 140% and a double-digit percentage beat in the US government segment, and it sees Palantir raising its full-year 2026 revenue growth guidance by roughly ten percentage points. International commercial business, in Citi's view, should accelerate as well.

Jefferies is not buying it. The same day, the firm reiterated Underperform with an $80 target, acknowledging Palantir's growth and profitability but calling the valuation rich after the stock's powerful run since the last earnings report. Harder second-half comparisons, mounting competition from leading AI labs and Databricks, and a consensus revenue estimate already sitting above company guidance all feed the bear case. Meeting its own targets, in other words, would fall short of what the market has come to expect.

The two views need not clash on operating strength at all. Where they part ways is on how much of that strength is already baked into the price — Citi looks for further upside surprises, while Jefferies sees precious little room for disappointment. StoneX, for its part, reaffirmed a Hold rating on Tuesday, also anticipating a strong quarter driven by US commercial and government demand. A bullish business outlook, as that split demonstrates, does not automatically produce a buy call.

The Bar Is Set Above Guidance

The numbers will land on 2 November after the US close, and the setup is unforgiving. Palantir's own revenue guidance stands at $2.160–2.164 billion, while the analyst consensus of $2.18 billion sits above the top end of that range. On adjusted earnings, analysts are looking for $0.41 per share, nearly double the $0.21 posted in the year-earlier quarter. Beyond the headline revenue figure, progress in the US business segments and any revision to the annual outlook will carry the most weight.

Shares slipped 2.6% on Wednesday, showing that Citi's upbeat note was not enough to prevent a down day. Until the report arrives, two threads run in parallel: analysts anticipate robust demand, while European customers keep probing questions of control and data sovereignty. Mosley's reassurance addresses part of that unease, but it is no substitute for evidence of fresh orders.